Potential value of HPV integration testing in a triage management for HPV-positive women
10.3760/cma.j.cn112141-20250320-00094
- VernacularTitle:HPV整合检测在HPV阳性妇女分流管理中的潜在价值
- Author:
Jingjing LI
1
;
Wenyan GUAN
;
Chengzhuo CHU
;
Yiqiang CHEN
;
Siyuan LIU
;
Guanghao PENG
;
Ying ZHANG
;
Qiao WENG
;
Ying HONG
;
Yun GU
Author Information
1. 南京大学医学院附属鼓楼医院精准医学科，南京 210008
- Publication Type:Journal Article
- Keywords:
Papillomaviridae;
Virus integration;
Papillomavirus infections;
Biomarkers;
Uterine cervical diseases;
High-throughput Nucleotide Sequencing;
Uterine cervic
- From:
Chinese Journal of Obstetrics and Gynecology
2025;60(10):788-797
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the dynamic characteristics of human papillomavirus (HPV) genomic integration during cervical lesion progression and the clinical value of HPV integration detection in stratify HPV-positive women, and to explore its molecular mechanisms in cervical carcinogenesis.Methods:A prospective cohort study was designed to enroll high-risk HPV (HR-HPV) positive women who underwent cervical cancer screening in Drum Tower Hospital Affiliated to Nanjing University Medical School and Nanjing Maternity and Child Health Care Hospital from July 2022 to July 2024. Cervical exfoliated cells samples were collected, and HPV whole genome targeted capture and high-throughput sequencing technology were used. The HPV integration patterns, host gene functional region distribution and pathway enrichment characteristics of 157 samples with different cervical lesions grades were analyzed, including 31 cases of normal cervix, 40 cases of cervical intraepithelial neoplasia (CIN) Ⅰ, 32 cases of CIN Ⅱ, 42 cases of CIN Ⅲ, and 12 cases of cervical cancer.Results:HR-HPV integration was detected in 80.2% (126/157) of the 157 HR-HPV positive samples. The incidence of HR-HPV integration in cervical cancer patients was 12/12, which was higher than that in normal women (77%, 24/31). The incidence of HPV16 integration was significantly higher in high-grade lesions, and the incidence of HPV16 integration was 43% (18/42) in CIN Ⅲ patients and 8/12 in cervical cancer patients ( P<0.001). A total of 14 438 integration events were detected in 126 samples with HPV integration. The integration sites were mainly distributed in the host intergenic region (51.0%, 7 359/14 438) and intronic region (38.1%, 5 494/14 438), and the integration frequency of viral L1 gene was the highest (28.4%, 4 498/16 781). Functional enrichment analysis showed that HPV integration-related host genes were significantly enriched in transport of small molecules,cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG) signaling pathway, and purine ribonucleotide biosynthetic process, which synergistically drove carcinogenesis through multiple mechanisms. Conclusions:HPV integration events are significantly associated with the progression of cervical lesions. HPV integrated detection based on cervical exfoliated cells is expected to optimize the current screening strategy, reduce excessive intervention of HPV positive women and facilitate their accurate triage management.
